a 37-year-old Thai male
Anti-PLA2R antibody-positive membranous nephropathy with nephrotic syndrome, plus a distal tubule problem that caused very low potassium
He responded well to prednisolone and oral cyclophosphamide. As the nephrotic syndrome went into remission, his low potassium got better at the same time.
In one man, treating anti-PLA2R membranous nephropathy with steroids and cyclophosphamide put the nephrotic syndrome into remission, and his dangerously low potassium got better at the same time.
- This is a single case report of a 37-year-old Thai man, not a study of many patients.
- His membranous nephropathy was confirmed two ways, by kidney biopsy and by an anti-PLA2R antibody blood test.
- His low potassium was severe enough to cause rhabdomyolysis, which is muscle breakdown, and his urine tests pointed to a distal tubule problem as the cause.
- Doctors ruled out hormone causes of low potassium, because renin, aldosterone, and a dexamethasone suppression test were all negative.
- As the kidney disease went into remission on prednisolone and oral cyclophosphamide, the potassium problem eased at the same time, which suggests the two were linked.
Why it might work
The paper frames the low potassium as a rare side effect of the membranous nephropathy itself, coming from the kidney's distal tubule, rather than from a separate hormone problem. Because the doctors checked and found no hormonal cause, they treated the underlying immune kidney disease with prednisolone, a steroid, and oral cyclophosphamide, a drug that calms the immune attack. As that treatment brought the nephrotic syndrome under control, the tubule appears to have recovered too, so the potassium came back up at the same time the protein leakage stopped.
The honest limits
- This is n=1, a single patient, so it cannot tell you how often this works or for whom.
- The abstract gives no timeframe, no potassium numbers, and no follow-up length, so we do not know how fast or how lasting the improvement was.
- The report describes an extremely rare tubule problem that the authors say had not been recognized before, so it is not the typical membranous nephropathy picture.
- Prednisolone and cyclophosphamide carry real risks that the abstract does not weigh, and it discloses no information about conflicts of interest.
- Have I been tested for the anti-PLA2R antibody, and what does my result mean for my type of kidney disease?
- Should my potassium and other electrolytes be checked, and could my kidney disease be affecting them?
- If immune-suppressing drugs like prednisolone or cyclophosphamide are ever suggested for me, what are the benefits and risks in my case?